All three H2020 projects (PROMISS, AFFIRMO, I-CARE4OLD) address health challenges specific to older populations with multiple conditions.
EUROPEAN UNION GERIATRIC MEDICINE SOCIETY AISBL
Pan-European geriatric medicine society contributing clinical expertise on elderly care, multimorbidity, and data-driven decision support to research consortia.
Their core work
EUGMS is the pan-European professional society representing geriatric medicine practitioners and researchers. They contribute clinical expertise on elderly care — particularly around managing complex, multi-condition patients — to EU research consortia. Their role in projects focuses on translating geriatric clinical knowledge into decision-support tools, care protocols, and nutritional interventions for older adults in home and institutional settings.
What they specialise in
AFFIRMO directly targets atrial fibrillation in frail, polymedicated older people; I-CARE4OLD addresses complex chronic conditions requiring coordinated medication strategies.
I-CARE4OLD applies big data, machine learning, and algorithmic decision support to individualize care for older persons.
PROMISS focused specifically on prevention of malnutrition in senior subjects across the EU.
How they've shifted over time
EUGMS's earliest H2020 involvement (PROMISS, starting 2016) focused on nutritional health and malnutrition prevention among seniors — a relatively traditional public health concern. By 2021, their portfolio shifted decisively toward technology-assisted clinical care: I-CARE4OLD brought in machine learning and algorithmic decision support, while AFFIRMO tackled integrated care for patients with multiple conditions and medications. The trajectory shows a clear move from prevention-oriented research toward data-driven, personalized geriatric medicine.
EUGMS is moving toward digitally-enabled, personalized care models for complex elderly patients — expect future involvement in AI-assisted clinical decision-making and integrated care platforms.
How they like to work
EUGMS operates exclusively as a participant, never as coordinator — consistent with their role as a professional society contributing clinical domain expertise rather than managing research programs. They work in large consortia (51 unique partners across just 3 projects), which means they are comfortable in complex, multi-partner environments. Their value to consortia is as the authoritative voice of European geriatric medicine, providing clinical validation and professional network access.
Despite only 3 projects, EUGMS has collaborated with 51 unique partners across 20 countries, reflecting the broad reach of their professional network across European geriatric medicine. Their collaboration footprint is remarkably wide for a small project portfolio.
What sets them apart
EUGMS is not a research lab or university — it is the professional society for geriatric medicine across Europe, which gives it unique convening power and clinical credibility. For consortium builders, EUGMS brings instant access to a continent-wide network of geriatricians and clinical practitioners who can validate research against real-world care settings. No other H2020 partner can offer the same combination of clinical authority and pan-European geriatric medicine reach.
Highlights from their portfolio
- I-CARE4OLDLargest EUGMS grant (EUR 215,769), combining machine learning and big data with geriatric care — representing their move into digital health.
- AFFIRMOTargets the high-impact intersection of atrial fibrillation, frailty, and polypharmacy — a clinically urgent problem with few integrated solutions.